BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 23328670)

  • 1. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.
    Sévère N; Dieudonné FX; Marie PJ
    Cell Death Dis; 2013 Jan; 4(1):e463. PubMed ID: 23328670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Implication of the ubiquitin ligase c-Cbl in bone formation and tumorigenesis].
    Sévère N; Marie P
    Med Sci (Paris); 2012 Nov; 28(11):970-5. PubMed ID: 23171901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
    Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
    J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis.
    Sehat B; Andersson S; Girnita L; Larsson O
    Cancer Res; 2008 Jul; 68(14):5669-77. PubMed ID: 18632619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination.
    Sévère N; Miraoui H; Marie PJ
    J Biol Chem; 2011 Jul; 286(27):24443-50. PubMed ID: 21596750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
    Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
    J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.
    Joazeiro CA; Wing SS; Huang H; Leverson JD; Hunter T; Liu YC
    Science; 1999 Oct; 286(5438):309-12. PubMed ID: 10514377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
    Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
    J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.
    Chan W; Tian R; Lee YF; Sit ST; Lim L; Manser E
    J Biol Chem; 2009 Mar; 284(12):8185-94. PubMed ID: 19144635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cbl-b and c-Cbl negatively regulate osteoblast differentiation by enhancing ubiquitination and degradation of Osterix.
    Choi YH; Han Y; Lee SH; Jin YH; Bahn M; Hur KC; Yeo CY; Lee KY
    Bone; 2015 Jun; 75():201-9. PubMed ID: 25744063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis.
    Sévère N; Dieudonné FX; Marty C; Modrowski D; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
    J Bone Miner Res; 2012 Oct; 27(10):2108-17. PubMed ID: 22623369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway.
    Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R
    J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
    Paolino M; Choidas A; Wallner S; Pranjic B; Uribesalgo I; Loeser S; Jamieson AM; Langdon WY; Ikeda F; Fededa JP; Cronin SJ; Nitsch R; Schultz-Fademrecht C; Eickhoff J; Menninger S; Unger A; Torka R; Gruber T; Hinterleitner R; Baier G; Wolf D; Ullrich A; Klebl BM; Penninger JM
    Nature; 2014 Mar; 507(7493):508-12. PubMed ID: 24553136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E3 Ubiquitin Ligase-Mediated Regulation of Osteoblast Differentiation and Bone Formation.
    Shen J; Fu B; Li Y; Wu Y; Sang H; Zhang H; Lin H; Liu H; Huang W
    Front Cell Dev Biol; 2021; 9():706395. PubMed ID: 34513836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Regulation of E3 Ubiquitin Ligases Cbl and its Cross-talking in Bone Homeostasis.
    Yang X; Hao D; He B
    Curr Stem Cell Res Ther; 2021; 16(6):683-687. PubMed ID: 32652923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases.
    Tang R; Langdon WY; Zhang J
    Front Endocrinol (Lausanne); 2022; 13():971162. PubMed ID: 35966060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Syk-binding ubiquitin ligase c-Cbl mediates signaling-dependent B cell receptor ubiquitination and B cell receptor-mediated antigen processing and presentation.
    Katkere B; Rosa S; Drake JR
    J Biol Chem; 2012 May; 287(20):16636-44. PubMed ID: 22451666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cbl interacts with multiple E2s in vitro and in cells.
    Liyasova MS; Ma K; Voeller D; Ryan PE; Chen J; Klevit RE; Lipkowitz S
    PLoS One; 2019; 14(5):e0216967. PubMed ID: 31120930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of Lck by Cbl ubiquitin ligase.
    Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases.
    Mohapatra B; Ahmad G; Nadeau S; Zutshi N; An W; Scheffe S; Dong L; Feng D; Goetz B; Arya P; Bailey TA; Palermo N; Borgstahl GE; Natarajan A; Raja SM; Naramura M; Band V; Band H
    Biochim Biophys Acta; 2013 Jan; 1833(1):122-39. PubMed ID: 23085373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.